Back to Running Shoes List
New Balance Ellipse v1
Beginner
Recommended for beginners. The Ellipse v1 is New Balance's 2026 daily light-activity shoe, combining FuelCell energy return with Fresh Foam X soft cushioning for a comfortable, balanced ride. The 38mm heel / 30mm forefoot provides ample everyday protection with an 8mm drop. The lightweight build and snug fit make running enjoyable for beginners, while also serving well for commuting and light exercise.

New Balance Ellipse v1

382
Basic Information
BrandNew Balance
ModelEllipse v1
Year2026
Gender VersionUnisex
Category Daily Slow Run Daily Training Light Exercise 5-10km Short Run Commute
TerrainAsphalt
Technical Specifications
Midsole TechnologyFuelCell + Fresh Foam X
Carbon Plate StructureNone
Upper MaterialEngineered Mesh
Outsole ConfigurationFull Rubber
Forefoot Thickness30.0mm
Heel Thickness38.0mm
Drop8mm
Weight260g
Wearing Experience
Fit Snug
Breathability (3/5)
Stability Medium
Cushion Distribution Even
Feel Attribute Balanced
Bounce (3/5)
Runner Matching
Running Style Recommendation Neutral
Runner Level Beginner
Weight Range Medium
Width Standard
Arch Type Medium
Landing Type Midfoot
Practical Information
Price
$112.37
Purchase links Durability600 km Overall Rating 4.0
User Review Summary

The New Balance Ellipse v1 features a dual-layer midsole combining FuelCell and Fresh Foam X technologies for responsive energy return and plush cushioning. With a 38mm heel / 30mm forefoot stack and 8mm drop, it provides ample impact protection for various running styles. The lightweight engineered mesh upper offers a snug fit with moderate breathability, while the full rubber outsole ensures reliable traction and durability. As New Balance's 2026 entry-level daily trainer, the Ellipse v1 is ideal for beginners, commuting, casual workouts, and everyday wear.

Video
Similar Recommendations
Performance Rating Chart
Official Rating
CharityAdvertise
《人吶,為什麽要跑步》
《人吶,為什麽要跑步》

從邵老師帶起的熱潮,到港台跑者的相遇,這部片串連出跑步在我們生命中的深刻意義:行動的勇氣、陪伴的溫度,以及自我探索的力量。這部片值得每個在路上或即將起跑的你細細品味

Coffee
Comment
Submit Comment
Remaining characters: 120